Nocebo effects encompass negative responses to inert interventions in the research setting
and negative outcomes with active treatments in the clinical research or practice settings …

Over the years, biologic agents have proven their importance in the management of chronic
autoimmune diseases, such as rheumatoid arthritis, psoriasis, and inflammatory bowel …

Abstract In addition to the general clinical benefit offered, biosimilars may not only generate
savings for healthcare budgets but also improve patient access to biologic products. Since …

Introduction: The nocebo effect is defined as a negative effect of a pharmacological or non-
pharmacological medical treatment that is induced by patients' expectations, and that is …

BACKGROUND: Several authors have hypothesized that adverse drug events (ADEs) upon
switching from reference biologics to biosimilar products are related to the nocebo effect …

The act of nonmedical switching, defined as switching stable patients who are generally
doing well with their current therapy from an originator biologic to its biosimilar, has been …

The nocebo effect is defined as the incitement or the worsening of symptoms induced by any
negative attitude from non-pharmacological therapeutic intervention, sham, or active …

Background Despite the benefits biosimilars offer in terms of cost savings and patient
access, healthcare professionals and patients have been reluctant to use them. Next to …

Nocebo effects are noxious reactions to therapeutic interventions that occur because of
negative expectations of the patient. In the past decade, neurobiological data have revealed …

Early diagnosis and treatment of rheumatoid arthritis (RA) are of critical importance to halt
the progression of the disease. Optimal use of advanced imaging techniques or biomarkers …